Broncho-Vaxom adults 7mg #30

Broncho-Vaxom instruction for use

Reed more and buy Broncho-Vaxom on this page

Composition

Capsules Broncho-Vaxom contain a lyophilizate of bacterial lysates (Moraxella catanhalis, Haemophilus influenzae, Staphylococcus aureus, Klebsiella pneumoniae, Streptococcus viridans, Klebsiella ozaenae, Streptococcus pneumoniae, Streptococcus pyogenes).
In addition, they contain the following additional components: propyl gallate, mannitol, magnesium stearate, indigotine, gelatin, anhydrous sodium glutamate, gelatinized starch, titanium dioxide.

Form of issue

The drug is sold in the form of capsules in contour packs (each of 10 pieces). They are contained in cardboard packs. Each has 1 or 3 contoured packages.

pharmachologic effect

The drug is an immunostimulating agent.

Pharmacodynamics and pharmacokinetics

The drug has an immunostimulating effect. It increases the formation of immunoglobulins A, G, M, secreted by the mucosa of the respiratory tract. In addition, it increases the number of T-lymphocytes.
When using this medicine, the risk of infection during airway infection epidemics is reduced, in addition, the severity of the disease and the time of its prolongation are reduced. The risk of bacterial complications after acute respiratory infections is also significantly reduced.

Indications for use

For adults and children, the medicine is used for the following indicators:
    the need to prevent re-infection of the respiratory tract;
    the need to prevent exacerbation of bronchitis;
    acute respiratory tract infections.

Contraindications

The drug is contraindicated in:
    children under six months;
    breastfeeding;
    the first trimester of pregnancy;
    hypersensitivity to its constituents.

Side effects

Unwanted adverse reactions with the use of the drug are very rare, but in rare cases nausea, coughing, headaches, dyspepsia, dyspnea are possible.
In addition, excessive fatigue and allergies can occur. There were also reports of cases of idiopathic urticaria, purpura, tachycardia, thrombocytopenia, arthralgia. But their relationship with the Bronho-Vaxom course has not yet been proved.
If you experience side effects, you should immediately contact a specialist who must decide whether to continue treatment.

Instructions for use (Method and dosage)

Adult and children's Bronho-Vaxom is used inside.
Adults and children from 12 years old should take one capsule of Bronho-Vax adult every day before meals in the morning until the symptoms disappear. The course is designed for at least 10 days. If you need another course of treatment, its duration should be determined by a specialist, based on the patient's condition.
In the prevention of exacerbations and maintenance therapy, the daily regimen is the same. The course is designed for three cycles (in each of them - 10 days), the gap between them is 20 days.
Capsules can be opened and mixed with water, fruit juice, milk and other beverages.
For children from 6 months to 12 years, experts appoint Bronho-Vax child. This drug should also be taken on a capsule a day in the morning before meals. It is recommended to calculate the course for 10 days. The contents of the capsule can be dissolved in water, juice, tea.
If necessary, the treatment can be repeated. So, to achieve maximum effect, some patients are prescribed three courses with interruptions of 20 days between them.

Overdose

Information on cases of overdose is absent.

Interaction

The interaction of this drug with other drugs has not been studied.

Storage conditions

The optimum temperature is 15-25 ° C. Capsules should be stored in their original packaging.
Shelf life - 5 years.

Reviews

Broncho-Vaxom reviews are mostly positive. Patients note that it helps to transfer the disease in a lighter form, and also to avoid complications in the future. Many, however, require not one, but several courses of therapy. The side effects are not reported.